家族性地中海热及淀粉样变性患者肝、胰、脾、肾的剪切波弹性成像评估
这项前瞻性研究纳入27例FMF患者、11例淀粉样变性患者和38例健康对照,用剪切波弹性成像测量肝、脾、双肾和胰腺的硬度。合并淀粉样变性的FMF患者肝、脾、肾、胰腺硬度中位数均显著高于对照组,且肝硬度显著高于无淀粉样变性的FMF患者;脾、胰腺和左肾硬度与CRP、ESR、SAA等炎症指标呈正相关。作者认为SWE可能成为FMF患者及淀粉样沉积无创随访的潜在工具。
要点
- FMF合并淀粉样变性时肝、脾、肾、胰腺SWE硬度均高于健康对照。
- FMF患者无论是否合并淀粉样变性,肾硬度均显著高于对照。
- 脾、胰腺、左肾硬度与CRP、ESR、SAA等炎症指标正相关。
核心结论
- SWE测量的肝、脾、肾、胰腺硬度在FMF合并淀粉样变性患者中显著升高,可能反映淀粉样沉积。
- FMF患者肾硬度升高在有无淀粉样变性时均出现,而肝硬度升高更特异于合并淀粉样变性者。
- 器官硬度与CRP、ESR、SAA等炎症指标正相关,提示急性炎症也可增加组织硬度。
研究设计与样本
- 前瞻性研究,纳入27例FMF患者、11例淀粉样变性患者和38例健康对照。
- 采用剪切波弹性成像测量肝、脾、双肾和胰腺的中位剪切波弹性值。
- 比较各组间弹性值,并用t检验和Mann-Whitney U检验比较实验室指标,用Spearman相关分析弹性值与实验室参数的关系。
关键影像表现/征象
- FMF合并淀粉样变性组肝、脾、肾、胰腺中位弹性值显著高于对照组。
- FMF组(无论是否合并淀粉样变性)肾中位硬度显著高于对照组。
- FMF合并淀粉样变性组肝中位硬度显著高于无淀粉样变性的FMF组。
诊断标准与关键数值
- 脾硬度与CRP(p=0.001,r=0.56)、ESR(p=0.001,r=0.61)、SAA(p=0.002,r=0.53)呈正相关。
- 胰腺硬度与CRP(p=0.006,r=0.48)、ESR(p=0.001,r=0.61)呈正相关。
- 左肾硬度与ESR(p=0.004,r=0.51)呈正相关。
临床应用与阅片要点
- 对FMF患者行腹部SWE检查时,可同时评估肝、脾、双肾和胰腺硬度。
- 肝硬度升高合并淀粉样变性时需警惕淀粉样沉积,肾硬度升高可见于FMF本身。
- 解读硬度值时需结合CRP、ESR、SAA等炎症指标,急性炎症也可能导致硬度增高。
局限性
- 样本量较小(FMF 27例、淀粉样变性11例、对照38例),结论需更大样本验证。
- 原文未报告SWE设备型号、探头频率、测量深度及操作者重复性等细节。
- 原文未给出诊断阈值、敏感度、特异度或AUC,无法用于定量诊断切点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Amyloid deposits in a visceral organ can contribute to tissue stiffness that could be measured with shear wave elastography (SWE). We aimed to investigate changes in organ stiffness in conjunction with laboratory parameters in patients with Familial Mediterranean Fever (FMF) and amyloidosis.
METHODS: This prospective study included 27 FMF patients, 11 patients with amyloidosis, and 38 healthy controls. Median shear wave elasticity values of the liver, spleen, both kidneys, and pancreas on SWE were compared among study and control groups. The mean values of CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate) were compared by the t-test and the median of SAA (serum amyloid A protein) was compared with the Mann-Whitney U test between FMF groups with and without amyloidosis. Spearman's correlation analysis was performed to reveal the association between stiffness values and laboratory parameters.
RESULTS: The median liver, spleen, kidney, and pancreas elasticity values were significantly higher in the FMF group with amyloidosis compared to control subjects. The median kidney stiffness values in the FMF group with or without amyloidosis were significantly higher compared to control subjects. Median liver stiffness values in FMF patients with amyloidosis were significantly higher than FMF patients without amyloidosis. There were statistically significant positive correlations between the CRP (p = 0.001, r = 0.56), ESR (p = 0.001, r = 0.61), and SAA (p = 0.002, r = 0.53) levels with spleen stiffness, and CRP (p = 0.006, r = 0.48) and ESR (p = 0.001,r = 0.61) levels with pancreas stiffness, and ESR (p = 0.004, r = 0.51) levels with the left kidney stiffness.
CONCLUSION: SWE could be a potential tool for noninvasive follow-up of FMF patients and also amyloid deposition.
ADVANCES IN KNOWLEDGE: Both acute inflammation and amyloidosis in the FMF patients could increase organ stiffness.
引用
- Bayramoglu Z, Akyol Sari ZN, Koker O, et al. Shear wave elastography evaluation of liver, pancreas, spleen and kidneys in patients with familial mediterranean fever and amyloidosis. Br J Radiol. 2021. PMID: 34520686. doi:10.1259/bjr.20210237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。